BIOADAPTIVES, INC. (BDPT)

Every figure below is the company's own, as filed. Nothing is estimated and nothing is smoothed — a period the filing does not support is left blank rather than drawn. Quarters are the company's own, counted from its financial year ending 12-31. Amounts in USD.

Revenue TTM

0 15K 30K 45K Q4 '19: 9.9K Q1 '20: 13.1K Q2 '20: 11.4K Q3 '20: 13.8K Q4 '20: 16.3K Q1 '21: 16.2K Q2 '21: 18.8K Q3 '21: 19.7K Q4 '21: 19.8K Q1 '22: 20.8K Q2 '22: 19K Q3 '22: 17K Q4 '22: 17.2K Q1 '23: 15K Q2 '23: 13K Q3 '23: 25.3K Q4 '23: 28.6K Q1 '24: 37.2K Q2 '24: 35.5K Q3 '24: 19.9K Q4 '24: 12.7K Q1 '25: 675 Q2 '25: 3.2K Q3 '25: 7.9K Q4 '25: 18.3K Q1 '26: 23.8K Q2 '26: 25.6K Q2 '20 Q2 '21 Q2 '22 Q2 '23 Q2 '24 Q2 '25 Q2 '26

Gross Profit TTM

0 7K 14K 21K Q4 '20: 6.1K Q1 '21: 5.3K Q2 '21: 8.5K Q3 '21: 10.6K Q4 '21: 10.1K Q1 '22: 9.6K Q2 '22: 8.4K Q3 '22: 7.2K Q4 '22: 7.1K Q1 '23: 7.2K Q2 '23: 6.5K Q3 '23: 9.2K Q4 '23: 10.8K Q1 '24: 12.4K Q2 '24: 11.4K Q3 '24: 6.7K Q4 '24: 4K Q1 '25: 429 Q2 '25: 1.1K Q3 '25: 4.9K Q4 '25: 12.5K Q1 '26: 16.6K Q2 '26: 19.8K Q1 '21 Q4 '21 Q3 '22 Q2 '23 Q1 '24 Q4 '24 Q3 '25 Q2 '26

Operating Income TTM

-2.7M -1.8M -900K 0 900K 1.8M 2.7M Q2 '14: -133.1K Q3 '14: -154.1K Q4 '14: -2.4M Q1 '15: -2.5M Q2 '15: -2.5M Q3 '15: -2.5M Q4 '15: -227.3K Q1 '16: -278.9K Q2 '16: -202.8K Q3 '16: -189K Q4 '23: -228.9K Q1 '24: -259.8K Q2 '24: -296.8K Q3 '24: -326.5K Q4 '24: -602.1K Q1 '25: -801.4K Q2 '25: -987.6K Q3 '25: -1.1M Q4 '25: -1M Q1 '26: -991.2K Q2 '26: -909.2K Q4 '14 Q3 '15 Q2 '16 Q1 '24 Q4 '24 Q3 '25 Q2 '26

Net Income TTM

-2.7M -1.8M -900K 0 900K 1.8M 2.7M Q2 '14: -271.6K Q3 '14: -292.8K Q4 '14: -2.6M Q1 '15: -2.6M Q2 '15: -2.5M Q3 '15: -2.5M Q4 '15: -227.4K Q1 '16: -278.9K Q2 '16: -202.8K Q3 '16: -189K Q4 '18: -1.4M Q1 '19: -1.3M Q2 '19: -1.1M Q3 '19: -478.5K Q4 '19: -238.9K Q1 '20: -569.3K Q2 '20: -819.9K Q3 '20: -778.4K Q4 '20: -847.2K Q1 '21: -1.1M Q4 '21: -1M Q1 '22: -925.2K Q2 '22: -839.8K Q3 '22: -1.1M Q4 '22: -895.6K Q1 '23: -815.6K Q2 '23: -735.7K Q3 '23: -472.4K Q4 '23: -712.5K Q1 '24: -732K Q2 '24: -771.1K Q3 '24: -795.7K Q4 '24: -899.2K Q1 '25: -789.6K Q2 '25: -764.5K Q3 '25: -1.1M Q4 '25: -1.6M Q1 '26: -1.5M Q2 '26: -1.2M Q1 '15 Q2 '16 Q3 '19 Q4 '20 Q3 '22 Q4 '23 Q1 '25 Q2 '26

Cost of Revenue TTM

0 9K 18K 27K Q4 '19: 5K Q1 '20: 6.1K Q2 '20: 7.9K Q3 '20: 10.9K Q4 '20: 10.2K Q1 '21: 10.9K Q2 '21: 10.2K Q3 '21: 9.1K Q4 '21: 9.7K Q1 '22: 11.2K Q2 '22: 10.7K Q3 '22: 9.8K Q4 '22: 10.1K Q1 '23: 7.9K Q2 '23: 6.5K Q3 '23: 16.2K Q4 '23: 17.7K Q1 '24: 24.7K Q2 '24: 24.1K Q3 '24: 13.1K Q4 '24: 8.6K Q1 '25: 246 Q2 '25: 2.2K Q3 '25: 2.9K Q4 '25: 5.8K Q1 '26: 7.2K Q2 '26: 5.8K Q2 '20 Q2 '21 Q2 '22 Q2 '23 Q2 '24 Q2 '25 Q2 '26

Operating Cash Flow TTM

-600K -400K -200K 0 200K 400K 600K Q2 '14: -45.5K Q3 '14: -34.3K Q4 '14: -58.6K Q1 '15: -51.9K Q2 '15: -33.2K Q3 '15: -43.5K Q4 '15: -72 Q1 '16: -1.4K Q2 '16: -835 Q3 '16: 10.8K Q4 '19: -168.1K Q1 '20: -163.5K Q2 '20: -171.3K Q3 '20: -173.4K Q4 '20: -106.9K Q1 '21: -124.9K Q2 '21: -134.4K Q3 '21: -133.1K Q4 '21: -158.7K Q1 '22: -159.4K Q2 '22: -206.8K Q3 '22: -235.2K Q4 '22: -227.3K Q1 '23: -185.6K Q2 '23: -165.4K Q3 '23: -160K Q4 '23: -223.8K Q1 '24: -245.5K Q2 '24: -240.1K Q3 '24: -240.3K Q4 '24: -249.5K Q1 '25: -306.2K Q2 '25: -365.8K Q3 '25: -460.7K Q4 '25: -516K Q1 '26: -503K Q2 '26: -436.4K Q3 '14 Q4 '15 Q1 '20 Q2 '21 Q3 '22 Q4 '23 Q1 '25 Q2 '26

Free Cash Flow TTM

Nothing in this filer's XBRL supports this figure for the periods asked for, so there is nothing to draw. That is a gap in the filing, not a zero.

Shares Outstanding Quarterly

0 250M 500M 750M Q3 '13: 10M Q1 '14: 12.1M Q2 '14: 12.6M Q3 '14: 12.6M Q1 '19: 22.6M Q1 '20: 18.9M Q3 '23: 730M Q1 '24: 7.7M Q2 '24: 3M Q3 '24: 8.2M Q1 '25: 9M Q2 '25: 9.5M Q3 '25: 10.2M Q1 '26: 12M Q2 '26: 281.2M Q3 '13 Q2 '14 Q1 '19 Q3 '23 Q2 '24 Q1 '25 Q3 '25 Q2 '26

Weighted average diluted, as the filer reports it for each period. An average cannot be added across periods, so this one is always shown per period the filer tagged rather than as a trailing year.

EPS TTM

-0.24 -0.16 -0.08 0.00 0.08 0.16 0.24 Q2 '14: -0.02 Q3 '14: -0.02 Q4 '14: -0.21 Q1 '15: -0.21 Q2 '15: -0.20 Q3 '15: -0.20 Q4 '15: -0.02 Q1 '16: -0.03 Q2 '16: -0.02 Q3 '16: -0.02 Q4 '18: -0.08 Q1 '19: -0.08 Q2 '19: -0.07 Q3 '19: -0.03 Q4 '19: -0.01 Q1 '20: -0.02 Q2 '20: -0.03 Q3 '20: -0.03 Q4 '20: -0.04 Q1 '21: -0.05 Q2 '24: -0.10 Q3 '24: -0.10 Q4 '24: -0.09 Q1 '25: -0.07 Q2 '25: -0.15 Q3 '25: -0.19 Q4 '25: -0.15 Q1 '26: -0.14 Q2 '26: -0.12 Q2 '14 Q2 '15 Q2 '16 Q2 '19 Q2 '20 Q2 '24 Q2 '25 Q2 '26

The filer's own published earnings a share for each quarter, four quarters added up. The company page divides trailing net income by the share count instead, which lands within about 1% of this and is not the same sum, so the two are named differently rather than presented as one figure.